U.S. to Resume Johnson & Johnson COVID-19 Vaccines Despite Rare Blood Clot Risk
U.S. health officials have lifted an 11-day pause on Johnson & Johnson vaccinations following a recommendation by an expert panel. Advisers to the Centers for Disease Control and Prevention…



